New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer -results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) Study

Supplementary Files
: Base case analysis results plus sensitivity analysis of patient testing pathway budget, average patient pathway cost of BRCA positive, and average patient pathway cost per genetic test offered for the 232 women eligible for the GTEOC study. In the GTEOC testing pathway all the patients were given the genetic test. The budget is the overall cost of all patients receiving eligibility checks, counselling and genetic testing plus post-test work-up i.e., the average cost per test offered is the total budget divided by the number of tests offered which is 232. For the current testing pathway, we calculated the Manchester score for all patients and based on this, 63 patients would have been eligible for genetic testing and offered the test. For these patients the full work-up cost was calculated from eligibility check to test and post-test work-up. For the base case we then assumed that 50% of the remaining 169 patients would have still been referred for genetic test counselling and so would incur those costs. We calculated for these 84 patients the cost of eligibility and genetic counselling but did not include test costs as these patients did not meet test criteria. For 
